The Impact of Varied Test Conditions on the In Vitro Activity of Tebipenem (SPR859) and Meropenem against Urinary Pathogens, Including Those Expressing Extended-Spectrum Beta-lactamases (ESBL)

The Impact of Varied Test Conditions on the In Vitro Activity of Tebipenem (SPR859) and Meropenem against Urinary Pathogens, Including Those Expressing Extended-Spectrum Beta-lactamases (ESBL)